The higher prevalence of BRCA2 mutations among families with OC in our study may be due to the preponderance of mutations identified in the ovarian cancer cluster region, and lend support to the increased risk of OC suggested to be conferred by mutations within this region relative to other BRCA2 mutations [38,39]. This evidence concerns the gene BRCA2 and ovarian carcinoma.